These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 9627688)
21. IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. Cooper KD; Hammerberg C; Baadsgaard O; Elder JT; Chan LS; Sauder DN; Voorhees JJ; Fisher G J Immunol; 1990 Jun; 144(12):4593-603. PubMed ID: 2191038 [TBL] [Abstract][Full Text] [Related]
22. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells. Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365 [TBL] [Abstract][Full Text] [Related]
23. Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2. Fleischmajer R; Kuroda K; Hazan R; Gordon RE; Lebwohl MG; Sapadin AN; Unda F; Iehara N; Yamada Y J Invest Dermatol; 2000 Nov; 115(5):771-7. PubMed ID: 11069613 [TBL] [Abstract][Full Text] [Related]
24. Vitamin D endocrine system and psoriasis vulgaris--review of the literature. Rucević I; Barisić-Drusko V; Glavas-Obrovac L; Stefanić M Acta Dermatovenerol Croat; 2009; 17(3):187-92. PubMed ID: 19818218 [TBL] [Abstract][Full Text] [Related]
25. Effect of vitamin D3 on the increased expression of Bcl-xL in psoriasis. Fukuya Y; Higaki M; Higaki Y; Kawashima M Arch Dermatol Res; 2002 Feb; 293(12):620-5. PubMed ID: 11875645 [TBL] [Abstract][Full Text] [Related]
26. Effects of 1,25-dihydroxyvitamin D3 and vitamin D3 on the expression of the vitamin d receptor in human skeletal muscle cells. Pojednic RM; Ceglia L; Olsson K; Gustafsson T; Lichtenstein AH; Dawson-Hughes B; Fielding RA Calcif Tissue Int; 2015 Mar; 96(3):256-63. PubMed ID: 25479835 [TBL] [Abstract][Full Text] [Related]
27. Association of 1 alpha,25-dihydroxyvitamin D3-occupied vitamin D receptors with cellular membrane acceptance sites. Kim YS; MacDonald PN; Dedhar S; Hruska KA Endocrinology; 1996 Sep; 137(9):3649-58. PubMed ID: 8756529 [TBL] [Abstract][Full Text] [Related]
28. Expression of Bcl-2 family proteins in psoriasis. Batinac T; Zamolo G; Hadzisejdić I; Zauhar G; Brumini G; Ruzić A; Persić V Croat Med J; 2007 Jun; 48(3):319-26. PubMed ID: 17589974 [TBL] [Abstract][Full Text] [Related]
29. Tissue specificity and mechanism of vitamin D receptor up-regulation during dietary phosphorus restriction in the rat. Sriussadaporn S; Wong MS; Pike JW; Favus MJ J Bone Miner Res; 1995 Feb; 10(2):271-80. PubMed ID: 7754807 [TBL] [Abstract][Full Text] [Related]
30. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells. Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237 [TBL] [Abstract][Full Text] [Related]
31. Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number. Albrechtsson E; Jonsson T; Möller S; Höglund M; Ohlsson B; Axelson J Pancreatology; 2003; 3(1):41-6. PubMed ID: 12649563 [TBL] [Abstract][Full Text] [Related]
32. Anchorage-dependent expression of the vitamin D receptor in normal human keratinocytes. Segaert S; Garmyn M; Degreef H; Bouillon R J Invest Dermatol; 1998 Oct; 111(4):551-8. PubMed ID: 9764832 [TBL] [Abstract][Full Text] [Related]
33. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428 [TBL] [Abstract][Full Text] [Related]
34. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. Bata-Csorgo Z; Hammerberg C; Voorhees JJ; Cooper KD J Clin Invest; 1995 Jan; 95(1):317-27. PubMed ID: 7529261 [TBL] [Abstract][Full Text] [Related]
35. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin. Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346 [TBL] [Abstract][Full Text] [Related]
36. Pilot study: immunohistochemistry expressions of vitamin D receptor associated with severity of disease in psoriasis patients. Chandra R; Roesyanto-Mahadi ID; Yosi A Int J Dermatol; 2020 Sep; 59(9):1092-1097. PubMed ID: 32592616 [TBL] [Abstract][Full Text] [Related]
37. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor. Harant H; Spinner D; Reddy GS; Lindley IJ J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570 [TBL] [Abstract][Full Text] [Related]
39. The molecular basis of hereditary 1,25-dihydroxyvitamin D3 resistant rickets in seven related families. Malloy PJ; Hochberg Z; Tiosano D; Pike JW; Hughes MR; Feldman D J Clin Invest; 1990 Dec; 86(6):2071-9. PubMed ID: 2174914 [TBL] [Abstract][Full Text] [Related]
40. The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Huhtakangas JA; Olivera CJ; Bishop JE; Zanello LP; Norman AW Mol Endocrinol; 2004 Nov; 18(11):2660-71. PubMed ID: 15272054 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]